Redmile as of March 31, 2011
Portfolio Holdings for Redmile
Redmile holds 35 positions in its portfolio as reported in the March 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Onyx Pharmaceuticals | 6.0 | $17M | 493k | 35.18 | |
| Zimmer Holdings (ZBH) | 6.0 | $17M | 286k | 60.53 | |
| Stryker Corporation (SYK) | 5.7 | $17M | 272k | 60.80 | |
| Sequenom | 5.7 | $16M | 2.6M | 6.33 | |
| St. Jude Medical | 5.6 | $16M | 314k | 51.26 | |
| UnitedHealth (UNH) | 5.2 | $15M | 329k | 45.20 | |
| Nektar Therapeutics (NKTR) | 5.1 | $15M | 1.6M | 9.47 | |
| Align Technology (ALGN) | 4.9 | $14M | 696k | 20.48 | |
| Auxilium Pharmaceuticals | 4.8 | $14M | 650k | 21.47 | |
| Ariad Pharmaceuticals | 4.5 | $13M | 1.7M | 7.52 | |
| DaVita (DVA) | 4.2 | $12M | 141k | 85.51 | |
| Masimo Corporation (MASI) | 3.9 | $11M | 342k | 33.10 | |
| Incyte Corporation (INCY) | 3.9 | $11M | 709k | 15.85 | |
| Aetna | 3.3 | $9.6M | 257k | 37.43 | |
| Pacific Biosciences of California (PACB) | 3.2 | $9.3M | 661k | 14.05 | |
| Baxter International (BAX) | 3.1 | $8.9M | 165k | 53.77 | |
| InterMune | 2.9 | $8.4M | 178k | 47.19 | |
| Affymax (AFFY) | 2.2 | $6.4M | 1.1M | 5.87 | |
| Celgene Corporation | 2.2 | $6.3M | 110k | 57.53 | |
| Allos Therapeutics | 2.1 | $6.0M | 1.9M | 3.17 | |
| BioSpecifics Technologies | 1.9 | $5.5M | 217k | 25.50 | |
| Anthera Pharmaceuticals | 1.8 | $5.3M | 780k | 6.76 | |
| CONMED Corporation (CNMD) | 1.8 | $5.2M | 199k | 26.28 | |
| Incyte Corp note 4.750%10/0 | 1.6 | $4.5M | 2.3M | 2.01 | |
| Dynavax Technologies Corporation | 1.5 | $4.4M | 1.6M | 2.76 | |
| BioMimetic Therapeutics | 1.4 | $4.0M | 304k | 13.11 | |
| TomoTherapy Incorporated | 1.3 | $3.8M | 829k | 4.57 | |
| Amarin Corporation (AMRN) | 1.0 | $3.0M | 406k | 7.30 | |
| Volcano Corporation | 0.9 | $2.6M | 101k | 25.60 | |
| Ym Biosciences | 0.6 | $1.8M | 697k | 2.64 | |
| Raptor Pharmaceutical | 0.6 | $1.9M | 540k | 3.45 | |
| LeMaitre Vascular (LMAT) | 0.6 | $1.6M | 237k | 6.81 | |
| Cyclacel Pharmaceuticals | 0.4 | $1.2M | 829k | 1.43 | |
| XenoPort | 0.1 | $441k | 74k | 5.93 | |
| Amicus Therapeutics (FOLD) | 0.0 | $84k | 12k | 7.06 |
